Position in PSNL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,042,894
+$7,611,308 QoQ
Shares Held
600,216
+388.1% QoQ
Ownership
0.562%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#24
of 157 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in PSNL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $173,824,007 across 15 Diagnostics & Research names. PSNL ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
123,380 | $64,952,167 | |
| 2 | TWST |
Twist Bioscience Corp
|
255,271 | $26,262,280 | |
| 3 | GH |
Guardant Health, Inc.
|
159,869 | $23,985,146 | |
| 4 | A |
Agilent Technologies, Inc.
|
76,048 | $10,101,455 | |
| 5 | NTRA |
Natera, Inc.
|
35,374 | $9,602,272 | |
| 6 | ICLR |
Icon PLC
|
48,182 | $8,369,695 | |
| 7 | PSNL |
Personalis, Inc.
This page
|
600,216 | $8,042,894 | |
| 8 | NEO |
Neogenomics Inc
|
435,783 | $6,358,073 |
All Filings in PSNL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,042,894 | 600,216 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $431,586 | 122,959 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $128,055 | 22,155 | Shares | Sole | 2025-02-12 | |
| 2021-03-31 | $598,023 | 24,300 | Shares | Sole | 2021-05-13 | |
| 2020-03-31 | $444,737 | 55,110 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||